Mangoceuticals IncNASDAQ:MGRX
- LAST PRICE2.5300
- TODAY'S CHANGE (%)0.0300 (1.2000%)
- Bid / Lots2.5100/ 1
- Ask / Lots2.5500/ 6
- Open / Previous Close2.4300 / 2.5000
- Day Range
- 52 Week Range
- Volume35,494
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGRX |
|---|---|---|
| 09:32 ET | 147 | 2.43 |
| 09:35 ET | 3000 | 2.42 |
| 09:39 ET | 500 | 2.495 |
| 09:48 ET | 1200 | 2.455 |
| 09:55 ET | 1745 | 2.46 |
| 09:57 ET | 155 | 2.46 |
| 10:15 ET | 100 | 2.46 |
| 10:18 ET | 100 | 2.45 |
| 10:20 ET | 235 | 2.46 |
| 10:24 ET | 1362 | 2.46 |
| 10:26 ET | 200 | 2.46 |
| 10:27 ET | 100 | 2.46 |
| 10:29 ET | 100 | 2.43 |
| 10:31 ET | 724 | 2.49 |
| 10:33 ET | 100 | 2.47 |
| 10:36 ET | 100 | 2.515 |
| 10:38 ET | 100 | 2.515 |
| 10:40 ET | 200 | 2.52 |
| 10:42 ET | 1687 | 2.55 |
| 10:44 ET | 100 | 2.52 |
| 10:45 ET | 100 | 2.49 |
| 10:47 ET | 100 | 2.52 |
| 10:54 ET | 200 | 2.525 |
| 10:58 ET | 300 | 2.525 |
| 11:00 ET | 100 | 2.52 |
| 11:03 ET | 457 | 2.525 |
| 11:05 ET | 166 | 2.54 |
| 11:07 ET | 100 | 2.5 |
| 11:09 ET | 243 | 2.54 |
| 11:12 ET | 277 | 2.52 |
| 11:14 ET | 1917 | 2.53 |
| 11:18 ET | 100 | 2.52 |
| 11:21 ET | 215 | 2.54 |
| 11:23 ET | 726 | 2.525 |
| 11:25 ET | 266 | 2.51 |
| 11:27 ET | 1533 | 2.52 |
| 11:30 ET | 100 | 2.525 |
| 11:34 ET | 100 | 2.525 |
| 11:39 ET | 100 | 2.54 |
| 11:41 ET | 100 | 2.525 |
| 11:48 ET | 1300 | 2.54 |
| 11:50 ET | 100 | 2.535 |
| 11:56 ET | 100 | 2.535 |
| 11:57 ET | 1100 | 2.535 |
| 11:59 ET | 122 | 2.55 |
| 12:01 ET | 225 | 2.535 |
| 12:03 ET | 145 | 2.55 |
| 12:08 ET | 1454 | 2.54 |
| 12:10 ET | 800 | 2.5375 |
| 12:12 ET | 300 | 2.5202 |
| 12:14 ET | 100 | 2.54 |
| 12:15 ET | 100 | 2.535 |
| 12:17 ET | 100 | 2.55 |
| 12:19 ET | 100 | 2.535 |
| 12:21 ET | 100 | 2.55 |
| 12:24 ET | 100 | 2.535 |
| 12:26 ET | 100 | 2.55 |
| 12:28 ET | 100 | 2.535 |
| 12:33 ET | 100 | 2.53 |
| 12:39 ET | 150 | 2.5035 |
| 12:42 ET | 100 | 2.5 |
| 12:44 ET | 100 | 2.515 |
| 12:51 ET | 100 | 2.53 |
Oct 31, 2024
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mangoceuticals Inc | 6.2M | -0.4x | --- |
Medical Care Technologies Inc | 5.6M | 0.0x | --- |
NewGenIvf Group Ltd | 5.5M | -2.6x | --- |
CompuMed Inc | 5.3M | -29.1x | --- |
Kindly MD Inc | 5.8M | -1.8x | --- |
Mainz Biomed NV | 4.6M | -0.2x | --- |
Company Information
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
Contact Information
- Headquarters
- 15110 Dallas Pkwy, Suite 600DALLAS, TX, United States 75248
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Jacob Cohen
- President, Company Secretary, Director
- Jonathan Arango
- Chief Financial Officer
- Eugene Johnston
- Chief Operating Officer
- Amanda Hammer
- Independent Director
- Lorraine Dalessio
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.2M |
|---|---|
Revenue (TTM) | $755.0K |
Shares Outstanding | 2.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.88 |
Book Value | $0.54 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 8.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,173.82% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
